DOJ Guilty Plea Highlights Narco-Terrorism, Money Laundering, and Extradition Risks

The Justice Department announced June 30 that a Honduras-based Chinese national extradited from Guatemala has pleaded guilty in the United States to narcotics trafficking conspiracy, money laundering conspiracy, and providing material support to the Cartel de Jalisco Nueva Generación, or CJNG. The plea stands out because it brings together several enforcement themes that are increasingly important in federal criminal practice: transnational narcotics distribution, cartel-related financial networks, material-support allegations, and cross-border extradition.

Although the matter may not draw the same immediate attention as a Supreme Court opinion or a blockbuster antitrust suit, it is significant for lawyers tracking how the government is framing cartel prosecutions.

SEC Hits Merrill Lynch With $7.5 Million Penalty Over Suspicious Activity Reporting Lapses

The SEC has imposed a $7.5 million penalty on Merrill Lynch, Pierce, Fenner Smith Inc., the Bank of America brokerage unit, over failures tied to suspicious activity reporting. The enforcement action centers on allegations that Merrill Lynch did not file a sufficient number of suspicious activity reports, or SARs, despite obligations designed to help detect potential money laundering and other illicit activity through customer accounts.

For securities lawyers and compliance professionals, the case is a reminder that anti-money-laundering controls remain a live enforcement priority even when the underlying issue is not an affirmative fraud charge.

Twitch Brings New PTAB Challenge in IPR2026-00397

Twitch Interactive, Inc. has launched a new proceeding at the Patent Trial and Appeal Board, filing inter partes review petition IPR2026-00397 on June 29, 2026. For patent litigators and in-house IP teams, the case is worth watching both for what it may reveal about Twitch’s broader patent risk strategy and for how the Board approaches the prior art and validity issues raised in the petition.

At this early stage, the PTAB docket reflects the filing of the petition, but practitioners will want to monitor the record closely for the patent owner’s preliminary response, the Board’s institution decision, and any related district court litigation that may shape the parties’ positions.

New PGR Targets America Ugreen Patent at the PTAB

A new post-grant review, PGR2026-00062, was filed at the Patent Trial and Appeal Board on June 25, 2026, putting an America Ugreen Limited patent directly in the PTAB spotlight.

Supreme Court Signals Broader Vulnerability for Independent Agencies

The Supreme Court’s latest action backing President Trump’s firing of an FTC member is likely to reverberate well beyond the Federal Trade Commission. For lawyers tracking the administrative state, the immediate takeaway is not just about one personnel dispute—it is about the Court’s growing willingness to reconsider how much insulation Congress can give independent agencies from presidential control.

That shift matters because many enforcement and rulemaking frameworks rest on the assumption that certain regulators can operate with a measure of independence from the White House.

FY2026 Appropriations Law Locks In Judiciary and Legal-System Funding

Congress has already completed a key piece of legal-system business for fiscal year 2026: the Consolidated Appropriations Act, 2026 is now law, including both the Judiciary Appropriations Act, 2026 and the Financial Services and General Government Appropriations Act, 2026. The legislation, H.R. 7148, is not headline-grabbing in the way a major Supreme Court ruling or enforcement action might be. But for lawyers and court watchers, it is highly consequential.

At a basic level, appropriations determine how well the federal judiciary can function.

Thorne Research Faces New PTAB Challenge in IPR2026-00400

A new inter partes review filed at the Patent Trial and Appeal Board could be one to watch for companies operating at the intersection of life sciences, nutraceuticals, and consumer health. In IPR2026-00400, the proceeding is captioned Thorne Research, Inc. and was filed on June 22, 2026.

At this early stage, the PTAB docket signals that a patent challenge involving Thorne Research is underway, but practitioners should note that key details—including the specific patent claims at issue, the identity of the petitioner and patent owner as reflected in the styled papers, and the precise invalidity combinations asserted—may develop as the record fills out.

Thorne Research IPR2026-00400 Puts Supplement Patent Strategy in Focus

A new inter partes review, IPR2026-00400, was filed on June 22, 2026, at the Patent Trial and Appeal Board against Thorne Research, Inc. The proceeding is one to watch for companies operating at the intersection of dietary supplements, formulations, and health-focused consumer products, where patent value often turns on how broadly claims are drafted and how well they withstand validity attacks based on published prior art.

At this stage, the publicly available docket information identifies Thorne Research, Inc. as the patent owner, but practitioners should review the petition and related filings to confirm the specific challenged patent, the real parties in interest, and the exact claims at issue as the record develops.

Sunday Snapshot: The 8 Legal Developments Shaping U.S. Litigation at the End of June 2026

The legal news cycle does not fully stop for the weekend, and this Sunday’s landscape reflects a familiar reality for practitioners: the most consequential developments often emerge over several days and quickly reshape litigation risk, enforcement expectations, and appellate strategy.

As of June 28, 2026, the biggest U.S. legal stories span multiple fronts rather than a single blockbuster filing.

Supreme Court Reverses and Remands in No. 24-699: What the Bare Judgment Signals

In a terse entry that simply states “Judgment REVERSED and case REMANDED,” the Supreme Court has disposed of docket No. 24-699 without, at least from the information currently available, a full explanatory opinion in the case details provided. Even so, that kind of action from the Court is significant for litigants and appellate practitioners because it immediately alters the posture of the case and signals that the lower court’s judgment cannot stand.

At the most basic level, reversal means the Supreme Court concluded the decision below was wrong in some material respect.

New PGR Targets Ugreen Patent at the PTAB

A new post-grant review, PGR2026-00062, was filed at the Patent Trial and Appeal Board on June 25, 2026, in a matter captioned America Ugreen Limited. While the publicly available docket caption immediately identifies Ugreen as a party, patent professionals will want to watch for the petition, mandatory notices, and patent owner filings to clarify the full party alignment, the challenged claims, and the commercial context behind the dispute.

At this stage, the key takeaway is procedural as much as substantive: a post-grant review is only available for patents subject to the AIA’s first-inventor-to-file regime and allows challengers to press a broader range of invalidity theories than inter partes review.

DOJ Charges 15 in Direct Action Minnesota Case With Conspiracy, Threats, and Assault on Federal Officers

The Justice Department has announced a sweeping federal prosecution against 15 alleged members and associates of Direct Action Minnesota, a Minneapolis-based activist group the government describes as having antifa ties. According to the DOJ, the defendants face a mix of serious charges, including conspiracy to impede federal officers, interstate stalking and threats, solicitation of violence, assault on federal officers, and destruction of government property.

The matter appears in the District of Minnesota as USA v. Alm, et al, and it stands out not only because of the number of defendants, but also because of the government’s emphasis on alleged coordinated action against federal personnel.

FDIC Eyes Major Cutbacks to Living Wills and Deposit Insurance Charges

The Federal Deposit Insurance Corporation has proposed a notable pullback in two areas that have shaped large-bank compliance since the post-2008 reform era: resolution planning and deposit insurance assessments. If adopted, the changes would significantly ease “living will” obligations for large banks and reduce annual deposit-insurance costs by an estimated $4 billion.

Although this is not a courtroom dispute, it is the kind of regulatory shift that can drive substantial legal work across the financial sector.

FTC Locks In Order Against Illuminate Over Student Data Breach

The Federal Trade Commission has given final approval to its order against Illuminate Education, closing out a closely watched enforcement action arising from a data breach that exposed information tied to roughly 10.1 million students. For education companies and the schools that rely on them, the case is a sharp reminder that student-data security is now firmly in regulators’ crosshairs.

According to the FTC, Illuminate failed to reasonably secure sensitive student information, resulting in a breach with sweeping impact.

Supreme Court Revives Trump-Era Asylum Processing Policy

The U.S. Supreme Court has sided with the Trump administration in a closely watched asylum-processing dispute, overturning a lower-court ruling that had blocked the policy as unlawful. The decision gives the federal government wider room to structure how asylum claims are handled at the border and underscores the Court’s continued attention to the scope of executive authority in immigration enforcement.

At a high level, the case centered on whether the administration’s asylum-processing framework was consistent with governing immigration statutes and the procedural limits imposed by federal law.

Previous Posts Newer Posts